Fermenta Biotech Ltd share price logo

Fermenta Biotech Ltd

NSE: FERMENTA

BSE: 506414

Small Cap

Pharma Sector

₹470.75

-0.25

(-0.05%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Fermenta Biotech shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-61%

Searches for Fermenta Biotech on INDmoney have decreased by 61% over the last 30 days.

Key Events for Fermenta Biotech

Last Dividend Declared

₹3.75 per share, declared on 26/05/2026

View Dividend History

Fermenta Biotech Stock Performance

as on September 16, 2026 at 7:37 pm IST

  • Day's Low

    Day's High

    ₹450.00
    ₹476.40
    downward going graph

    4.41%

    Downside

    1.20%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹248.85
    ₹580.45
    downward going graph

    47.14%

    Downside

    23.30%

    Upside

    downward going graph

Fermenta Biotech share price movements today

Previous Close
₹471.00
Open
₹470.75
Volume
98.02K
Upper Circuit
₹565.20
Lower Circuit
₹376.80
Day's Low - High
₹450.00 - ₹476.40
52 Week Low - High
₹248.85 - ₹580.45

Fermenta Biotech Historical Returns

1 Month Return
+ 3.05 %
3 Month Return
+ 46.82 %
1 Year Return
+ 35.33 %
3 Year Return
+ 174.48 %
5 Year Return
+ 66.61 %

Fermenta Biotech Fundamentals

as on September 16, 2026 at 2:07 pm IST

Market Cap

₹1,386.20 Cr

Return on Equity (ROE)

16.01

PE Ratio (TTM)

23.02

Return on capital employed (ROCE)

18.77

Industry PE ratio

51.81

Beta (LTM)

0.4

P/B Ratio

2.16

Dividend Yield

1.15

PEG Ratio

-1.5

Quarterly Earnings Growth YOY

-55.88

EPS (TTM)

24.5

Book Value

141.68

Fermenta Biotech Stock Valuation

as on September 16, 2026 at 2:07 pm IST

Fermenta Biotech in the last 5 years

  • Overview

  • Trends

Lowest (-55.80x)

October 6, 2022

Today (23.02x)

September 11, 2026

Industry (51.81x)

September 11, 2026

Highest (473.02x)

September 6, 2022

LowHigh

Today’s Price to Earnings Ratio: 23.02x

Fermenta Biotech Technical Analysis

Track how Fermenta Biotech technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bearish

Moving Averages

Bearish

Neutral

Bullish

Bearish

Oscillators

Bearish

Neutral

Bullish

Neutral

Overall

Bearish9
Bullish4
Neutral2

Oscillators

Name

Value

Action

MACD level (12,26)
-0.05
Bearish
CCI (20)
-553.03
Bullish
RSI (14)
35.5
Neutral
Momentum (10)
-0.05
Neutral
ADI (14)
26.19
Bearish
Ultimate Oscillator (7,14,28)
75.97
Bullish

Moving Averages

Name

Value

Action

SMA (20)
471.06
Bearish
EMA (20)
471.18
Bearish
VWMA (20)
471.14
Bearish
SMA (50)
471.23
Bearish
EMA (50)
471.32
Bearish
SMA (200)
470.51
Bullish
EMA (200)
470.6
Bullish
KAMA (200)
471.23
Bearish
DEMA (200)
471.42
Bearish

Fermenta Biotech Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Fermenta Biotech with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Fermenta Biotech Ltd image
Fermenta Biotech Ltd
NA1,386.2013.32%0.6270525
Bacil Pharma Ltd image
Bacil Pharma Ltd
NA29.1947.69%0.001NA
Concord Biotech Ltd image
Concord Biotech Ltd
BUY15,409.9711.25%0.502591,054
Beryl Drugs Ltd image
Beryl Drugs Ltd
NA11.7921.54%0.00-121
Natco Pharma Ltd image
Natco Pharma Ltd
HOLD14,671.79-3.06%0.541,3714,078
See all

Fermenta Biotech Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
56.91
98.97
97.34
78.13
95.03
156.47
139.85
136.26
130.22
137.36
121.58
121.82
Other Income
1.9
2.52
5.38
2.82
2.88
2.23
3.89
8.77
5.43
3.12
14.14
4.37
Total Income
58.8
101.49
102.72
80.95
97.91
158.7
143.74
145.03
135.66
140.48
135.72
126.2
Expenses
78.25
73.85
91.97
77.33
76.25
103.2
102.9
108.03
103.59
114.59
101.58
103.77
Operating Profit
-21.34
25.12
5.37
0.8
18.78
53.27
36.95
28.23
26.63
22.77
20
18.05
Operating Profit Margin %
-37.5%
25.38%
5.52%
1.02%
19.76%
34.04%
26.42%
20.72%
20.45%
16.58%
16.45%
14.82%
Profit Before Interest, Tax and Depreciation
-19.45
27.64
10.76
3.62
21.66
55.5
40.84
37
32.07
25.89
34.14
22.43
Interest
3.69
5.19
3.39
3.43
3.69
4.08
2.99
3.11
2.58
3.03
2.82
2.54
Depreciation
5.93
6.38
6.46
6.12
6.15
6.08
5.86
5.81
5.41
5.37
5.11
5.2
Profit Before Tax
-29.07
16.07
0.91
-5.93
11.82
45.34
31.99
28.08
24.08
17.49
26.21
14.69
Tax Paid
-
6.08
8.05
-
0.7
7.45
-1.34
6.48
6.06
5.46
7.61
5.16
Profit After Tax
-29.07
9.99
-7.14
-5.93
11.12
37.89
33.32
21.6
18.03
12.02
18.6
9.53
Total Net profit including share of profit / Loss from associate company
-29.07
9.99
-7.14
-5.93
11.12
37.89
33.32
21.6
18.03
12.02
18.6
9.53
EPS
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
6.2
4.36
6.66
3.4
Actual EPS
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
6.2
4.36
6.66
3.4
Adjusted EPS
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.49
6.2
4.36
6.66
3.4
Diluted EPS
-7.32
3.41
-2.41
-2.01
3.94
12.71
11.79
7.47
6.15
4.34
6.61
3.34

Fermenta Biotech Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
302.67
404.67
292.95
377.29
398.52
349.94
335.66
469.48
525.43
Other Income
8.95
12.37
12.32
8.25
8.14
8.6
11.81
11.82
29.26
Total Income
311.62
417.04
305.27
385.54
406.65
358.54
347.47
481.3
554.69
Expenses
209.65
253.31
237.76
295.63
337.06
360.81
315.58
359.68
425.6
Operating Profit
93.02
151.36
55.19
81.66
61.46
-10.87
20.08
109.8
99.83
Operating Profit Margin %
30.73%
37.4%
18.84%
21.64%
15.42%
-3.11%
5.98%
23.39%
19%
Profit Before Interest, Tax and Depreciation
101.97
163.72
67.51
89.91
69.59
-2.28
31.89
121.62
129.09
Interest
13.63
23.13
9.09
17.97
17.08
20.78
17.05
14.19
11.54
Depreciation
12.36
11.89
15
20.31
25.56
28.25
24.72
24.22
21.7
Profit Before Tax
75.98
128.7
43.42
51.63
26.95
-51.31
-9.88
83.21
95.85
Tax Paid
21.13
10.81
-16.1
9.1
11.89
1.83
14.14
6.8
25.61
Profit After Tax
54.84
117.9
59.52
42.53
15.06
-53.13
-24.01
76.4
70.25
Total Net profit including share of profit / Loss from associate company
46.35
117.47
59.52
42.53
15.06
-53.13
-24.01
76.4
70.25
EPS
36.75
40.72
20.63
15.77
5.35
-17.7
-5.42
26.35
24.7
Actual EPS
36.75
40.72
20.63
15.77
5.35
-17.7
-5.42
26.35
24.7
Adjusted EPS
3.06
13.57
20.63
15.77
5.35
-17.7
-5.42
26.35
24.7
Diluted EPS
36.75
40.7
20.53
15.69
5.33
-17.7
-5.42
26.35
24.51

Fermenta Biotech Ltd Cash Flow

Figures in Rupees Crores

Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
4.44
1.91
59.26
90.34
34.46
62.6
43.44
116.11
105.35
40.9
92.83
Cash Flow from Investing Activities
-13.38
6.53
-101.14
-96.58
-43.66
-40.94
-26.04
-55.35
-15.5
-0.15
-43
Cash Flow from Financing Activities
10.42
-12.11
88.81
12.21
-47.44
-1.14
-21.58
-41.38
-90.86
-50.86
-42.28
Net Cash Flow
1.48
-3.68
46.93
5.99
-56.65
20.52
-4.17
19.37
-1
-10.12
7.55

Fermenta Biotech Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Jul 2026
Promoters
62.06%
62.06%
62.06%
62.06%
62.06%
64.09%
64.09%
64.09%
64.09%
64.09%
64.09%
64.09%
DII
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.04%
0.04%
FII
0%
0%
0%
0.05%
0.02%
0.02%
0.02%
0.02%
0.02%
0.02%
0.13%
0.35%
Public
36.05%
36.05%
36.11%
36.42%
36.97%
35%
35%
34.75%
33.99%
33.3%
33.2%
32.98%
Total Outstanding Shares
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
2,94,30,987
Total Shareholders
15,150
15,178
14,589
13,221
12,922
12,930
12,845
13,760
14,139
13,661
14,131
14,991

Mutual Funds Buying / Exiting Fermenta Biotech

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Fermenta Biotech

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

Bandhan BSE Healthcare Index Fund Direct Growth

Bandhan BSE Healthcare Index Fund Direct Growth

₹0.01 Cr

₹0.00 Cr (+4.84%)

0.03%

Mutual Funds Exiting Fermenta Biotech

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Fermenta Biotech Corporate Actions

View detailed summary of the earnings and dividend history of Fermenta Biotech.

  • Fermenta Biotech Ltd Earnings Results

    Fermenta Biotech Ltd’s net profit fell -55.38% since last year same period to ₹9.74Cr in the Q1 2026-2027. On a quarterly growth basis, Fermenta Biotech Ltd has generated -49.24% fall in its net profits since last 3-months.

    Read More about Earnings Results

  • Fermenta Biotech Ltd Dividends May,2026

    In the quarter ending March 2026, Fermenta Biotech Ltd has declared dividend of ₹3.75 per share on 26 May 2026 - translating a dividend yield of 0.79%.

    Read More about Dividends

Indices Featuring Fermenta Biotech Stock

Check stock indices that include Fermenta Biotech.

BSE Healthcare

₹50,357.80

-121.01 (▲0.24%)

Insights on Fermenta Biotech Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 0.13% to 0.35% in Jul 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 3 months, FERMENTA stock has moved up by 46.8%

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, FERMENTA has outperformed top 5 stocks with highest market-cap in Pharmaceuticals

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.8% return, outperforming this stock by 15.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 64.09% of holdings in Jul 2026 quarter

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 33.20% to 32.98% in Jul 2026 quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 19.19 Cr → 9.74 Cr (in ₹), with an average decrease of 49.2% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 140.48 Cr → 126.2 Cr (in ₹), with an average decrease of 5.2% per quarter

About Fermenta Biotech Ltd

DupharInterfran (DIL) was established by a technocrat, D V K Raju in 1951 as International Franchises Pvt Ltd. In the early years, the company manufactured and sold toothpaste, antiseptic lotion and pharmaceutical specialities on a loan licence basis, in collaboration with PhilipsDuphar Amsterdam Solvay Duphar and Crookes Laboratories London (participation up to 25% equity). The company changed its name to Crookes Interfran in 1963 and to DupharInterfran in 1971. In 1976, collaborations with Solvay Duphar for manufacturing Vitamin D3 and Isoxypurine hydrochloride, with 38.86% foreign stake, came up. In 1995, DIL launched a rights issue to increase long-term resources and working capital and sold two popular brands - Crocin and LactoCalamine lotion - to Smithkline Beecham Pharmaceuticals and Nicholas Piramal respectively to concentrate on the core business of ethical drugs. As per the Scheme of Arrangement, the pharma business of the company was also transferred to a new entity called Duphar Pharma India and investments in unutilised premises at Thane for a commercial complex with modern facilities were also made. In 2003, the Company expanded manufacturing capacity for Vitamin D and other products like Phenyramidol in Kullu. In 2010, the company signed a contract with Solvay Pharmaceuticals B V in Netherlands and acquired 990000 equity shares of Rs.10 each from Fermenta Biotech Ltd, making it a subsidiary. In 2012, the company launched Penicillin G Acylase catalyst Fermase PA 850 and successful entries of Annual Contract with Solvay Pharmaceuticals B V, a vasodilator. Since then, the company has launched new and improved products - fish oil derived cholesterol for the aquaculture market, Vitamin D 500 feed grade powder in 2020, Vitamin AD2 for oil fortification, and patented technology for enzymatic synthesis of Molnupiravir in 2021. It also established subsidiaries in Mauritius, Germany, and USA. The company changed its name from DIL Limited to Fermenta Biotech Limited (FBL) in 2019.

Revenue: ₹121.82Cr as on June 2026 (Q1 FY27)
Net Profit: ₹9.53Cr as on June 2026 (Q1 FY27)
Listing date: 20 Apr, 2026
Chairperson Name: Pradeep Manjunath Chandan
OrganisationFermenta Biotech Ltd
IndustryPharmaceuticals
CEOPradeep Manjunath Chandan
E-voting on sharesClick here to vote

FAQs

What is Fermenta Biotech share price today?

Fermenta Biotech share price today stands at ₹470.75 as on . Fermenta Biotech share today touched a day high of ₹476.4 and a low of ₹450.

What is the 52 week high and 52 week low range for Fermenta Biotech share?

Fermenta Biotech touched a 52 week high of ₹580.45 and a 52 week low of ₹248.85. Fermenta Biotech share price today i.e. is trending at ₹470.75, which is -18.90% down from its 52 week high and 89.17% up from its 52 week low.

What is Fermenta Biotech's market capitalisation today?

Fermenta Biotech market capitalisation is ₹1,386.20 Cr as on .

How to buy Fermenta Biotech shares?

To buy Fermenta Biotech shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for FERMENTA or Fermenta Biotech Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Fermenta Biotech shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Fermenta Biotech trading volume today?

Fermenta Biotech trading volume is 98.02K as on . This means that 98.02K shares of Fermenta Biotech were bought and sold on the stock market during today's trading session.